title: Use of budesonide in the treatment of microscopic colitis.
abstract: Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated.
authors.affiliation: Department of Medicine, The University of Western Ontario and London Health Sciences Centre, London, Ontario, Canada.
authors.forename: Vikram
authors.initials: V
authors.lastname: Tangri
authors.forename: Nilesh
authors.initials: N
authors.lastname: Chande
mesh_terms: D019819:Budesonide / Q000009:adverse effects / Q000627:therapeutic use*; D046728:Colitis, Microscopic / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction
chemical_list: D005938:Glucocorticoids; D019819:Budesonide